Fusion Pharmaceuticals Inc. (FUSN)

Fusion Pharmaceuticals Inc. (FUSN)
- Cap: $1.83B
- View FUSN Profile
- View Questions on FUSN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Fusion Pharmaceuticals Inc. (FUSN)
- Cap: $1.83B
- View FUSN Profile
- View Questions on FUSN

Q: Do you consider that today's news of a joint agreement with Astra Seneca is significant enough to open a full position in Fusion? My read is that the agreement confirms that AZ believes FUSION has the goods so to speak, and is relieving them of a huge part of the costs of development in exchange for a piece of the action. I like the deal but would like your opinion before I jump.
John

Read Answer Asked by JOHN on November 03, 2020

Fusion Pharmaceuticals Inc. (FUSN)
- Cap: $1.83B
- View FUSN Profile
- View Questions on FUSN

Q: I am watching Fusion Pharma and am considering buying because the drop in price from their IPO. This is a local story and would like to support the McMaster entry.

Read Answer Asked by Paul on August 26, 2020

Fusion Pharmaceuticals Inc. (FUSN)
- Cap: $1.83B
- View FUSN Profile
- View Questions on FUSN

Q: good morning, do you have any thoughts on FUSN. Prospects for growth, challenges etc. The company comes with a good pedigree but do you think that will translate into a successful business? thanks

Read Answer Asked by alex on August 04, 2020